WHY CANT CHELATION BE TAKEN BY MOUTH IN PILL FORM INSTEAD OF BY INTRAVENOUS INJECTION?
Chelation therapy is gaining recognition so rapidly that there is growing interest in developing an oral chelator that will produce benefits similar to intravenous EDTA chelation therapy. Many nutritional substances administered by mouth are known to have chelating properties but none have the spectrum of activity of intravenous EDTA. Many nutrients such as vitamin C and the amino acids cysteine and aspartic acid have the ability to weakly chelate metals. They also protect against free radical damage in other ways, as anti-oxidants. Claims are being increasingly made for the use of nutritional supplements containing weak chelators in patients with atherosclerosis. There is nothing new about these products which are mostly vitamins and minerals being aggressively marketed with glowing testimonials and deceptive marketing techniques. Benefit from products taken by mouth has never even come close to the much more dramatic results seen with intravenous EDTA. Recently some nutritional suppl